Gilead Reports Livdelzi ALP Normalization Results at Week 52
Gilead said 75.4% of Livdelzi recipients achieved ALP normalization at week 52, versus 16.1% of placebo recipients.
Related stories
Anheuser-Busch Shares Hit 7-year High
Anheuser-Busch shares increased to 76.32 EUR, the highest since October 2019. Over the past 4 weeks, Anheuser-Busch gained 12.82%, and in the last 12 months, it increased 39.96%.
L impact | EQUITY | Nov 05, 2026, 03:51 PM UTC
SOK Marketler Reports Q3 Revenue of 93.0 Billion Lira
Q3 revenue was 93.0 billion lira, versus 91.9 billion lira a year earlier.
M impact | EQUITY | Nov 05, 2026, 03:42 PM UTC
SOK Marketler Q3 Net Profit Rises to 989.1 Million Lira
SOK Marketler reported Q3 net profit of 989.1 million lira, versus 342.9 million lira a year earlier.
M impact | EQUITY | Nov 05, 2026, 03:42 PM UTC
Hackers steal US$133 million from French bank
Crédit Mutuel Arkéa announced that hackers invaded the French bank and diverted US$133 million.
M impact | EQUITY | Nov 05, 2026, 03:42 PM UTC
US Tech Shares Sink
The S&P 500 tumbled 2.6%, while the Nasdaq plunged 4.1%, officially entering correction territory. The Dow Jones also shed more than 800 points on Thursday, wiping out the previous
L impact | EQUITY | Nov 05, 2026, 03:42 PM UTC
Banco Mercantil Reports R$ 279.4 Million Third-Quarter Profit
Banco Mercantil reported profit of R$ 279.4 million in the third quarter, marking its 16th consecutive record.
M impact | EQUITY | Nov 05, 2026, 03:42 PM UTC